1 Department of Cardiothoracic Surgery Heart Center of the University Hospital of Cologne Germany.
2 Department of Thoracic and Cardiovascular Surgery West German Heart Center University of Duisburg-Essen Essen Germany.
J Am Heart Assoc. 2019 May 21;8(10):e012049. doi: 10.1161/JAHA.119.012049.
Background Coronary artery bypass grafting for acute coronary syndrome complicated by cardiogenic shock ( CS ) is associated with a high mortality. This registry study aimed to distinguish between early surgical outcomes of CS patients with non- ST -segment-elevation myocardial infarction ( NSTEMI ) and ST -segment-elevation myocardial infarction ( STEMI ). Methods and Results Patients with NSTEMI (n=1218) or STEMI (n=618) referred for coronary artery bypass grafting were enrolled in a prospective multicenter registry between 2010 and 2017. CS was present in 227 NSTEMI (18.6%) and 243 STEMI patients (39.3%). Key clinical end points were in-hospital mortality ( IHM ) and major adverse cardiocerebral events ( MACCEs ). Predictors for IHM and MACCEs were identified using multivariable logistic regression analysis. STEMI patients with CS were younger, had a lower prevalence of diabetes mellitus and multivessel disease, and exhibited higher myocardial injury (troponin 9±17 versus 3±6 ng/mL) before surgery compared with patients with NSTEMI ( P<0.05). Emergency coronary artery bypass grafting was performed more often in STEMI (58%) versus NSTEMI (40%; P=0.002). On-pump surgery with cardioplegia was the preferred surgical technique in CS . IHM and MACCE rates were 24% and 49% in STEMI patients with CS and were higher compared with NSTEMI ( IHM 15% versus MACCE 34%; P<0.001). Predictors for IHM and MACCE in CS were a reduced ejection fraction and a higher European System for Cardiac Operative Risk Evaluation score. Conclusions Surgical revascularization in NSTEMI and STEMI patients with CS is associated with a substantial but not prohibitive IHM and MACCE rate. Worse early outcomes were found for patients with STEMI complicated by CS compared with NSTEMI patients.
急性冠状动脉综合征并发心源性休克(CS)患者行冠状动脉旁路移植术的死亡率较高。本注册研究旨在区分非 ST 段抬高型心肌梗死(NSTEMI)和 ST 段抬高型心肌梗死(STEMI)合并 CS 患者的早期手术结果。
2010 年至 2017 年,连续纳入拟行冠状动脉旁路移植术的 NSTEMI(n=1218)或 STEMI(n=618)患者。227 例 NSTEMI 患者(18.6%)和 243 例 STEMI 患者(39.3%)合并 CS。主要临床终点为院内死亡率(IHM)和主要不良心脑血管事件(MACCEs)。采用多变量逻辑回归分析确定 IHM 和 MACCE 的预测因素。与 NSTEMI 患者相比,CS 合并 STEMI 患者更年轻,糖尿病和多血管疾病的患病率更低,术前心肌损伤(肌钙蛋白 9±17 比 3±6ng/mL)更高(P<0.05)。STEMI 患者更常接受急诊冠状动脉旁路移植术(58%比 40%;P=0.002)。心脏停搏下体外循环是 CS 的首选手术技术。CS 合并 STEMI 患者的 IHM 和 MACCE 发生率分别为 24%和 49%,高于 NSTEMI(IHM 15%比 MACCE 34%;P<0.001)。CS 患者 IHM 和 MACCE 的预测因素是射血分数降低和欧洲心脏手术风险评估系统评分较高。
CS 合并 NSTEMI 和 STEMI 患者的手术血运重建与相当但非不可避免的 IHM 和 MACCE 发生率相关。与 NSTEMI 患者相比,CS 合并 STEMI 患者的早期结果更差。